Tower Research Capital LLC (Trc) Mannkind Corp Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Mannkind Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 5,668 shares of MNKD stock, worth $31,627. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,668
Previous 42,343
86.61%
Holding current value
$31,627
Previous $221,000
84.16%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding MNKD
# of Institutions
255Shares Held
150MCall Options Held
1.62MPut Options Held
802K-
Black Rock Inc. New York, NY22.6MShares$126 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.1MShares$89.6 Million0.0% of portfolio
-
State Street Corp Boston, MA9.6MShares$53.6 Million0.0% of portfolio
-
Nitorum Capital, L.P. New York, NY9.16MShares$51.1 Million6.38% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.75MShares$48.8 Million0.83% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.44B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...